Some studies show evidence of kidney protection with GLP-1 RA treatment in patients with T2D and CKD; however, the underlying mechanisms and their independence from glycemia remain under investigation [5,86,87,88,89,90]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.